{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:41:37Z","timestamp":1790757697333,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:00:00Z","timestamp":1436400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00520-015-2807-5","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T05:37:18Z","timestamp":1436333838000},"page":"547-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Can pregabalin prevent paclitaxel-associated neuropathy?\u2014An ACCRU pilot trial"],"prefix":"10.1007","volume":"24","author":[{"given":"Shivani S.","family":"Shinde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Seisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamini","family":"Soori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Atherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre R.","family":"Pachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Lafky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Ruddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Loprinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,9]]},"reference":[{"issue":"11","key":"2807_CR1","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1200\/JCO.2010.33.0308","volume":"29","author":"CL Loprinzi","year":"2011","unstructured":"Loprinzi CL, Reeves BN, Dakhil SR et al (2011) Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol 29(11):1472\u20131478","journal-title":"J Clin Oncol"},{"issue":"6","key":"2807_CR2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PPO.0b013e31815a999b","volume":"13","author":"CL Loprinzi","year":"2007","unstructured":"Loprinzi CL, Maddocks-Christianson K, Wolf SL et al (2007) The paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism. Cancer J 13(6):399\u2013403","journal-title":"Cancer J"},{"issue":"20","key":"2807_CR3","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1002\/cncr.27489","volume":"118","author":"BN Reeves","year":"2012","unstructured":"Reeves BN, Dakhil SR, Sloan JA et al (2012) Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1. Cancer 118(20):5171\u20135178","journal-title":"Cancer"},{"issue":"14","key":"2807_CR4","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","volume":"22","author":"A Caraceni","year":"2004","unstructured":"Caraceni A, Zecca E, Bonezzi C et al (2004) Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 22(14):2909\u20132917","journal-title":"J Clin Oncol"},{"issue":"6","key":"2807_CR5","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1089\/jpm.2005.8.1118","volume":"8","author":"JR Ross","year":"2005","unstructured":"Ross JR, Goller K, Hardy J et al (2005) Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study. J Palliat Med 8(6):1118\u20131126","journal-title":"J Palliat Med"},{"issue":"4","key":"2807_CR6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.amjopharm.2005.12.008","volume":"3","author":"DR Guay","year":"2005","unstructured":"Guay DR (2005) Pregabalin in neuropathic pain: a more \u201cpharmaceutically elegant\u201d gabapentin? Am J Geriatr Pharmacother 3(4):274\u2013287","journal-title":"Am J Geriatr Pharmacother"},{"issue":"9","key":"2807_CR7","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/cncr.23008","volume":"110","author":"RD Rao","year":"2007","unstructured":"Rao RD, Michalak JC, Sloan JA et al (2007) Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 110(9):2110\u20132118","journal-title":"Cancer"},{"issue":"1","key":"2807_CR8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1200\/JCO.1999.17.1.434a","volume":"17","author":"H Deventer van","year":"1999","unstructured":"van Deventer H, Bernard S (1999) Use of gabapentin to treat taxane-induced myalgias. J Clin Oncol 17(1):434\u2013435","journal-title":"J Clin Oncol"},{"issue":"9","key":"2807_CR9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.2004.99.298","volume":"22","author":"VH Nguyen","year":"2004","unstructured":"Nguyen VH, Lawrence HJ (2004) Use of gabapentin in the prevention of taxane-induced arthralgias and myalgias. J Clin Oncol 22(9):1767\u20131769","journal-title":"J Clin Oncol"},{"issue":"2","key":"2807_CR10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/jpet.106.103614","volume":"318","author":"M Matsumoto","year":"2006","unstructured":"Matsumoto M, Inoue M, Hald A, Xie W, Ueda H (2006) Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther 318(2):735\u2013740","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"2807_CR11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1213\/ANE.0b013e318249d36e","volume":"115","author":"H Clarke","year":"2012","unstructured":"Clarke H, Bonin RP, Orser BA, Englesakis M, Wijeysundera DN, Katz J (2012) The prevention of chronic postsurgical pain using gabapentin and pregabalin: a combined systematic review and meta-analysis. Anesth Analg 115(2):428\u2013442","journal-title":"Anesth Analg"},{"issue":"11","key":"2807_CR12","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.clinthera.2006.11.017","volume":"28","author":"JE Tarride","year":"2006","unstructured":"Tarride JE, Gordon A, Vera-Llonch M, Dukes E, Rousseau C (2006) Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective. Clin Ther 28(11):1922\u20131934","journal-title":"Clin Ther"},{"key":"2807_CR13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2377-13-56","volume":"13","author":"K Athanasakis","year":"2013","unstructured":"Athanasakis K, Petrakis I, Karampli E, Vitsou E, Lyras L, Kyriopoulos J (2013) Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting. BMC Neurol 13:56","journal-title":"BMC Neurol"},{"issue":"10","key":"2807_CR14","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s11136-013-0379-8","volume":"22","author":"EM Lavoie Smith","year":"2013","unstructured":"Lavoie Smith EM, Barton DL, Qin R, Steen PD, Aaronson NK, Loprinzi CL (2013) Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 questionnaire. Qual Life Res 22(10):2787\u20132799","journal-title":"Qual Life Res"},{"issue":"8","key":"2807_CR15","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","volume":"41","author":"TJ Postma","year":"2005","unstructured":"Postma TJ, Aaronson NK, Heimans JJ et al (2005) The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 41(8):1135\u20131139","journal-title":"Eur J Cancer"},{"key":"2807_CR16","unstructured":"ClinicalTrials.gov. prevention and treatment of chemotherapy-induced peripheral neuropathy in subjects with advanced colorectal cancer. https:\/\/Clinicaltrials.gov\/ct2\/show\/NCT00380874 . Accessed 4014 Dec 25"},{"issue":"18","key":"2807_CR17","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","volume":"32","author":"DL Hershman","year":"2014","unstructured":"Hershman DL, Lacchetti C, Dworkin RH et al (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32(18):1941\u20131967","journal-title":"J Clin Oncol"},{"issue":"6","key":"2807_CR18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1155\/2014\/754693","volume":"19","author":"D Moulin","year":"2014","unstructured":"Moulin D, Boulanger A, Clark AJ et al (2014) Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag 19(6):328\u2013335","journal-title":"Pain Res Manag"},{"issue":"3","key":"2807_CR19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10549-010-1278-0","volume":"125","author":"DL Hershman","year":"2011","unstructured":"Hershman DL, Weimer LH, Wang A et al (2011) Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat 125(3):767\u2013774","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"2807_CR20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","volume":"49","author":"HN Bockbrader","year":"2010","unstructured":"Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P (2010) A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 49(10):661\u2013669","journal-title":"Clin Pharmacokinet"},{"key":"2807_CR21","doi-asserted-by":"crossref","unstructured":"Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ (2009) Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev (3):CD007076. doi: 10.1002\/14651858.CD007076.pub2","DOI":"10.1002\/14651858.CD007076.pub2"},{"issue":"16","key":"2807_CR22","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0707056","volume":"358","author":"JA Sparano","year":"2008","unstructured":"Sparano JA, Wang M, Martino S et al (2008) Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 358(16):1663\u20131671","journal-title":"N Engl J Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-015-2807-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2807-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:09:43Z","timestamp":1559095783000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-015-2807-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,9]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["2807"],"URL":"https:\/\/doi.org\/10.1007\/s00520-015-2807-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,9]]}}}